Showing results (521-530 of 538) with videos related to

Sort By:
Pageof 54
Nature Cancer|July 3, 2020
Discovering the anti-cancer potential of non-oncology drugs by systematic viability profilingSteven M Corsello, Rohith T Nagari, Ryan D Spangler, et al.
Biological Psychiatry|December 23, 2023
Deep Brain Stimulation for Obsessive-Compulsive Disorder: Optimal Stimulation SitesGarance M Meyer, Barbara Hollunder, Ningfei Li, et al.
Nature|July 6, 2017
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathwayVasanthi S Viswanathan, Matthew J Ryan, Harshil D Dhruv, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2025
PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical ModelsDejan Juric, Kyung Song, Radia M Johnson, et al.
Science Translational Medicine|September 3, 2025
An allele-agnostic mutant-KRAS inhibitor suppresses tumor maintenance signals and reprograms tumor immunity in pancreatic cancerKathleen M McAndrews, Francesca Paradiso, Clint A Stalnecker, et al.
Cerebral Cortex (New York, N.Y. : 1991)|March 22, 2021
Microscale Physiological Events on the Human Cortical SurfaceAngelique C Paulk, Jimmy C Yang, Daniel R Cleary, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
Tumor-selective effects of active RAS inhibition in pancreatic ductal adenocarcinomaUrszula N Wasko, Jingjing Jiang, Alvaro Curiel-Garcia, et al.
Nature Communications|June 5, 2019
Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastomaPratiti Bandopadhayay, Federica Piccioni, Ryan O'Rourke, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Activating Ras-MAPK pathway variants drive hippocampal clonal competition in human epilepsySattar Khoshkhoo, Mingyun Bae, Yilan Wang, et al.
Pageof 54